SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-009742
Filing Date
2022-05-12
Accepted
2022-05-12 16:52:36
Documents
13
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ymtx-20220512.htm   iXBRL 8-K 69781
2 EX-99.1 ymtx-ex99_1.htm EX-99.1 130984
  Complete submission text file 0000950170-22-009742.txt   337882

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ymtx-20220512.xsd EX-101.SCH 2488
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ymtx-20220512_lab.xml EX-101.LAB 18598
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ymtx-20220512_pre.xml EX-101.PRE 11594
7 EXTRACTED XBRL INSTANCE DOCUMENT ymtx-20220512_htm.xml XML 4709
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 22918667
SIC: 2834 Pharmaceutical Preparations